A Penn institute that accelerates the process by which scientific discoveries are translated into practical applications for patients has been awarded $54.8 million by the National Institutes of Health.
The Institute for Translational Medicine and Therapeutics is among 10 institutions that will receive a total of $498 million from NIH’s Clinical and Translational Science Awards program to expand their work over the next five years.
“These institutes were the pioneers in this program and are to be commended for the work they have done in bridging the traditional divides between laboratory research and medical practice,” Barbara Alving, director of the NIH’s National Center for Research Resources, which oversees the CTSA program, said in a statement.
“They were tasked with transforming the way their institutions coordinate research to make it more proactive and effective in producing real-world results, and in the process, they have served as innovative models nationwide,” she added.
Two other Ivy League universities received funding — Yale University was awarded $45.4 million and Columbia University was given $38.9 million. The University of California at San Francisco received the most funding of the 10 institutions — an award of $112 million.
Penn’s ITMAT is housed in the $370-million Translational Research Center, which opened this May.
The Daily Pennsylvanian is an independent, student-run newspaper. Please consider making a donation to support the coverage that shapes the University. Your generosity ensures a future of strong journalism at Penn.
DonatePlease note All comments are eligible for publication in The Daily Pennsylvanian.